A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2011
08/30/2011	US8008378 Taste-masked composition of cationic exchange resin
08/30/2011	US8008355 Endosomolytic poly(vinyl ether) polymers
08/30/2011	US8008349 Stable pharmaceutical preparation comprising levothyroxine sodium, gelatin and fillers and which is free of organic solvent residues
08/30/2011	US8008345 Preventing, alleviating symptoms of a skin condition with a complexes, such as lauryliminodipropionic acid tocopheryl phosphate; penetrating and absorption into skin; inflammation, erythema, wound, burn, dermatitis, gingivitis, sunburn, heat burn, psoriasis; cosmetics
08/30/2011	US8008308 Phosphonate compounds
08/30/2011	US8008266 Nucleic acids containing unmethylated cytosine-guanine dinucleotides activate lymphocytes and redirect an immune response from th2 to th1
08/30/2011	US8008255 Methods and compositions for enhanced transmucosal delivery of peptides and proteins
08/30/2011	US8008077 Photochemical internalization for delivery of molecules into the cytosol
08/30/2011	US8007830 Oral granules of montelukast sodium; e.g. spray-dried mannitol coated with said drug; may be ingested directly or mixed with food or other comestibles for patients who have difficulty swallowing
08/30/2011	US8007793 Stabilized liquid anti-RSV antibody formulations
08/30/2011	US8007777 Controlled release system composition for administration of a biological component, preferably, a probiotic bacterium
08/30/2011	US8007774 Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
08/30/2011	US8007752 Process for preparing oral calcium compositions
08/30/2011	CA2566496C Pharmaceutical compositions and methods for peptide treatment
08/30/2011	CA2545880C Erythropoietin solution formulation
08/30/2011	CA2536401C Compositions of quaternary ammonium compounds containing bioavailability enhancers
08/30/2011	CA2489259C Polymeric micelle complexes of low molecular weight antitumor agents and styrene maleic acid copolymers
08/30/2011	CA2479665C Nanoparticulate compositions of angiogenesis inhibitors
08/30/2011	CA2436407C Polymer conjugates of neublastin and methods of using same
08/25/2011	WO2011103559A1 Oligomer modified diaromatic substituted compounds
08/25/2011	WO2011103440A1 Skin disinfectant composition and methods for manufacturing and using
08/25/2011	WO2011102724A2 Disinfectant composition and its use in dental treatment
08/25/2011	WO2011102655A2 Composition for percutaneous administration of tolterodine with reduced skin irritation
08/25/2011	WO2011102506A1 Sustained-release solid preparation for oral use
08/25/2011	WO2011102505A1 Sustained-release solid preparation for oral use
08/25/2011	WO2011102504A1 Sustained-release solid preparation for oral use
08/25/2011	WO2011102407A1 Radiation therapy agent
08/25/2011	WO2011102123A1 Novel dextrin fatty acid ester that does not cause gelation of liquid oil, and uses thereof
08/25/2011	WO2011101830A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and clobetasone, and a process to make it
08/25/2011	WO2011101828A1 A medicinal fusidic acid cream made using sidium fusidate and incorporating a biopolymer and betamethasone, and a process to make it
08/25/2011	WO2011101826A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, terbinafine and dexamethasone, and a process to make it
08/25/2011	WO2011101825A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, clotrimazole and clobetasone, and a process to make it
08/25/2011	WO2011101824A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, miconazole, dexamethasone, and a process to make it
08/25/2011	WO2011101823A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating biopolymer, clotrimazole and dexamethasone, and a process to make it
08/25/2011	WO2011101457A1 Chimeric surface active proteins
08/25/2011	WO2011100984A1 Gelatin, a curcumin drug carrier system
08/25/2011	WO2011100983A1 Casein, a novel curcumin drug carrier system
08/25/2011	WO2011100841A1 Pd-1 modulation and uses thereof for modulating hiv replication
08/25/2011	WO2011100829A1 Bifunctional chelating agents
08/25/2011	WO2011078457A3 Ph-sensitive block copolymer forming polyionic complex micelle, and drug or protein delivery vehicle using same
08/25/2011	WO2011063156A3 Acid salt forms of polymer-drug conjugates and alkoxylation methods
08/25/2011	WO2011037976A3 Pramipexole pharmaceutical formulations
08/25/2011	WO2011009797A3 Plasma-adapted and balanced gelatin solution
08/25/2011	WO2011003822A3 Aqueous insulin preparations containing methionine
08/25/2011	US20110207896 Sterically Hindered Poly(ethylene glycol) Alkanoic Acids and Derivatives Thereof
08/25/2011	US20110207834 Highly purified polylactic acid or a derivative thereof, a salt of the same, and purification method thereof
08/25/2011	US20110207833 Metallic pigment preparation in compacted form, method for producing the same and use thereof
08/25/2011	US20110207832 Skin disinfectant composition and methods for manufacturing and using
08/25/2011	US20110207826 Lactose and cellulose-based tableting aid
08/25/2011	US20110207813 Pharmaceutical composition with gelling properties containing a tyrosine derivative
08/25/2011	US20110207786 Potentiated Biocidal Compositions and Methods of Use
08/25/2011	US20110207764 Cyclopolysaccharide compositions
08/25/2011	US20110206772 Polysaccharide composition and methods of isolation of the emulsion stabilizing cationic polyelectrolytic polysaccharide
08/25/2011	US20110206763 Rapid-release encapsulation composition
08/25/2011	US20110206757 Novel glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof
08/25/2011	US20110206756 Dithiocarbamate metal chelates and methods of making and using thereof
08/25/2011	US20110206755 Methods and products for manipulating uncoupling protein expression
08/25/2011	US20110206633 Polymer conjugates of cd-np peptides
08/25/2011	US20110206631 Ion binding polymers and uses thereof
08/25/2011	US20110206630 Surfactant and cleaning compositions comprising microbially produced branched fatty alcohols
08/25/2011	US20110206617 Modified polysaccharides for drug and contrast agent delivery
08/25/2011	US20110206610 Compositions and methods for enhancing drug delivery across and into epithelial tissues
08/25/2011	US20110206606 Stable radiopharmaceutical compositions and methods for preparation
08/25/2011	CA2790134A1 Pd-1 modulation and uses thereof for modulating hiv replication
08/25/2011	CA2789337A1 Hsa-related compositions and methods of use
08/24/2011	EP2360258A2 Aprotinin polypeptides for transporting a compound across the blood-brain barrier
08/24/2011	EP2360252A1 Immunostimulatory nucleic acid molecules comprising GTCGTT motifs
08/24/2011	EP2360203A1 Novel multi-arm polyethylene glycol, preparation method and uses thereof
08/24/2011	EP2360188A1 Hyaluronic acid derivative and pharmaceutical composition thereof
08/24/2011	EP2360169A2 PSMA antibodies
08/24/2011	EP2359864A2 Targeting Vector-Phospholipid Conjugates
08/24/2011	EP2359863A2 Isolation and use of solid tumor stem cells
08/24/2011	EP2359862A1 Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents
08/24/2011	EP2359861A1 Inclusion complexes of pinocembrin with cyclodextrin or its derivatives
08/24/2011	EP2359860A2 Polymer micelle composition for treatment of resistant cancer cells
08/24/2011	EP2359859A1 Compositions comprising albumin nanoparticles and methods of delivery of pharmacological agents
08/24/2011	EP2359856A1 Formulation of human antibodies for treating TNF-alpha associated disorders
08/24/2011	EP2359852A1 Novel cancer targeting therapy using complex of substance capable of binding specifically to constituent factor of cancer stroma and anti-tumor compound
08/24/2011	EP2359845A1 Inhalant comprising modified superoxide dismutase
08/24/2011	EP2359835A1 Viral infection therapeutic drug containing polyalkyleneimine
08/24/2011	EP2359830A1 Controlled released preparations of oxcarbazepine having sigmoidal release profile
08/24/2011	EP2359827A1 Adhesive material containing 5-methyl-1-phenyl-2-(1h)-pyridone
08/24/2011	EP2359690A1 Multiplication of the effectiveness of anti-infective agents by a composition including both a dispersant agent and a metal reversal agent
08/24/2011	EP2358770A2 Zwitterionic polymers with therapeutic moieties
08/24/2011	EP2358404A2 Allografts combined with tissue derived stem cells for bone healing
08/24/2011	EP2358396A2 Method of preparing polyglutamate conjugates
08/24/2011	EP2358395A1 Method and formulation for reducing aggregation of a macromolecule under physiological conditions
08/24/2011	EP2358394A1 Method and formulation for reducing aggregation of a macromolecule under physiological conditions
08/24/2011	EP2358393A1 Therapeutic protein formulations
08/24/2011	EP2358378A2 Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof
08/24/2011	EP2358359A2 Ceramic honeycomb structure skin coating
08/24/2011	EP2358358A2 Tablets and discs with compartments with two or more drugs for release at certain intervals and with specific rates
08/24/2011	EP2358355A1 Pharmaceutical composition of a potent hcv inhibitor for oral administration
08/24/2011	EP1856155B1 Monoclonal antibodies and immunodetection assay specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor
08/24/2011	EP1827409B1 Rasagiline orally disintegrating compositions
08/24/2011	EP1694311B1 Chewable soft capsules containing ungelatinized starch
08/24/2011	EP1537868B1 Antifungal medicinal compositions
08/24/2011	EP1506774B1 Smooth muscle peristole inhibitor
08/24/2011	EP1505990B1 Methods of treating hepatitis
08/24/2011	EP1423404B1 RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA)

1 ... 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 ... 1712